ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production

Abstract

Background

Allergy and allergic asthma are significant health burdens in developed countries and are increasing in prevalence. Dendritic cells (DCs) initiate immune responses to common aeroallergens and ADAM10 has been demonstrated to be important for the development of adaptive responses. This study's objective was to understand the role of ADAM10 on DCs in the development of allergic and anaphylactic responses.

Methods

In this study we used mouse models of allergic airway inflammation (house dust mice and Alternaria alternata) and OVA-induced models of active anaphylaxis to determine the DC-specific function of ADAM10 and Notch signaling. To examine T_H1 and T_H17 immunity infection with Anaplasma phagocytophilum and Citrobacter rodentium were used.

Results

Mice, which have ADAM10 deleted from DCs, have dramatic reductions in IgE production and do not develop significant T_H2 immune responses. Further, ADAM10^DC-/- mice are resistant to IgE-mediated anaphylaxis. This response is selective for T_H2 immunity as T_H1 and T_H17 immunity are largely unaffected. Notch1, a known ADAM10 substrate, when knocked out of DCs (Notch1^DC-/-) demonstrated a similar reduction in anaphylaxis and IgE. Without ADAM10 and Notch1 signaling, DCs were unable to make cytokines that stimulate T_H2 cells and cytokines. Anaphylaxis and allergic lung inflammation were restored in ADAM10^DC-/- with the overexpression of the Notch1-intracellular domain, confirming the role of Notch signaling.

Conclusions

Targeting ADAM10 and Notch1 on DCs represent a novel strategy for modulating T_H2 immune responses and IgE production.

This article is protected by copyright. All rights reserved.

http://ift.tt/2uwjGly